SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MultiCell Technologies, Inc.
MCET 0.000001000-90.0%Jun 6 1:41 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: jimpit5/31/2011 6:22:47 PM
   of 237
 
MultiCell Technologies is Granted Stem Cell Patent...!

MultiCell Technologies is Granted Stem Cell Patent
Press Release Source: MultiCell Technologies, Inc.
Tuesday May 31, 2011, 8:30 am EDT

"WOONSOCKET, R.I., May 31, 2011 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board:MCET.ob - News) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver disease. Under the terms of its license agreement with Rhode Island Hospital, MultiCell Technologies is the worldwide exclusive licensee of U.S. patent 7,935,528..."

-MORE-
finance.yahoo.com

__________________________________________________________________

Jim

.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext